GlassScriptPhysician profile
Samir Pradeep Shirodkar
NPI 1679774459
$1,375.26
in general payments reported to CMS, 2019-2025
14 companies · $60.08 in 2025
The $60.08 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $381 · 2021: $305 · 2022: $92.74 · 2023: $61.71 · 2024: $194 · 2025: $60.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $310 · Education: $5.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $310.48 |
| Education | $5.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $416.40 | 2020-2022 | |
| Astellas Pharma US INC | $315.64 | 2019-2025 | Veozah, Myrbetriq |
| Coloplast Corp | $176.92 | 2020-2024 | |
| Mckesson Medical-Surgical, INC. | $93.50 | 2019 | |
| Procept Biorobotics Corporation | $93.15 | 2024 | Aquabeam System |
| Pfizer INC. | $72.55 | 2019-2023 | |
| Boston Scientific Corporation | $50.72 | 2020-2025 | Axonics |
| Karl Storz Lithotripsy-America | $36.70 | 2021 | |
| Endo Pharmaceuticals INC. | $34.45 | 2020 | |
| Edap Technomed INC | $30.05 | 2022 | |
| Clarus Therapeutics INC. | $17.22 | 2021 | |
| Sumitomo Pharma America, INC. | $17.15 | 2025 | Gemtesa |
| Tolmar Pharmaceuticals, INC. | $15.25 | 2022 | |
| Travere Therapeutics, INC. | $5.56 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Shirodkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.